Th1 and Th2 Immune Response in Chronic Hepatitis B Patients during a Long-Term Treatment with Adefovir Dipivoxil

Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

(2008) Patrick Marcellin et al.   HEPATOLOGY

Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir

(2008) Nancy Leung et al.   HEPATOLOGY

Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B

(2008) Maurizia Rossana Brunetto et al.   HEPATOLOGY

Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B

(2008) Joseph J.Y. Sung et al.   JOURNAL OF HEPATOLOGY

Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations

(2008) Jessica Tan et al.   JOURNAL OF HEPATOLOGY

Hepatitis B Virus Genotype-Associated Variability in Antiviral Response to Adefovir Dipivoxil Therapy in Chinese Han Population

(2008) Ai-Zhong Zeng et al.   TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE

Therapeutic strategies in the management of patients with chronic hepatitis B virus infection

(2007) George V Papatheodoridis et al.   LANCET INFECTIOUS DISEASES